TG Therapeutics (TGTX) net assets (shareholders' equity)

Net assets · fiscal 2025
$648.02M

TG Therapeutics (TGTX) had net assets of $648.02M at the end of fiscal 2025 (December 31, 2025). That is 191.4% higher than the $222.36M of fiscal 2024. Figures as of 19 Nov 2026, 11:21 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Net assets, fiscal 2025
$648.02M
Change on fiscal 2024
+191.4%
Growth, 5 years
+4.5% a year
Growth, 10 years
+20.4% a year
Highest on record
$648.02Mfiscal 2025
Lowest on record
$9.62Mfiscal 2011
Fiscal years on record
152011–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

TG Therapeutics net assets (shareholders' equity), in more detail

Over the five fiscal years to 2025 net assets grew at a compound 4.5% a year; over ten years the rate was 20.4% a year. Across the 15 fiscal years on record (2011–2025), the highest was $648.02M in fiscal 2025 and the lowest $9.62M in fiscal 2011.

History · 15 fiscal years

Net assets by fiscal year

TG Therapeutics net assets (shareholders' equity), year by year

TG Therapeutics (TGTX) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$648.02M 191.4% up
2024$222.36M 38.5% up
2023$160.50M 174.0% up
2022$58.59M 75.3% down
2021$237.15M 54.3% down
2020$519.35M 1,244.9% up
2019$38.62M 60.7% up
2018$24.04M 64.1% down
2017$66.99M 86.8% up
2016$35.87M 64.7% down
2015$101.57M 26.8% up
2014$80.10M 100.0% up
2013$40.05M 157.6% up
2012$15.55M 61.6% up
2011$9.62M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

More on TGTX

TG Therapeutics, figure by figure

TG Therapeutics (TGTX) overview: price, valuation and scorecardAll health care companies by market value

TG Therapeutics net assets (shareholders' equity): questions and answers

What are TG Therapeutics's net assets?

TG Therapeutics (TGTX) had net assets of $648.02M at the end of fiscal 2025 (December 31, 2025). That is 191.4% higher than the $222.36M of fiscal 2024.

What is the growth rate of TG Therapeutics's net assets?

Over the five fiscal years to 2025 net assets grew at a compound 4.5% a year; over ten years the rate was 20.4% a year.

What are the highest and lowest net assets figures on record for TG Therapeutics?

Across the 15 fiscal years on record (2011–2025), the highest was $648.02M in fiscal 2025 and the lowest $9.62M in fiscal 2011.

How is TG Therapeutics's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For TG Therapeutics it is on record here for 15 fiscal years, 2011 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “TG Therapeutics (TGTX) net assets (shareholders' equity)”, data as of 19 November 2026. https://funkfolio.com/stock/TGTX/net-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.